Kidney removal after immunotherapy may offer cure for select patients
NCT ID NCT06882486
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether removing the kidney after successful immunotherapy can help patients with metastatic kidney cancer stop all treatment and stay cancer-free. About 60 adults whose tumors have shrunk significantly with immunotherapy will either have surgery and stop therapy, or continue therapy without surgery. The goal is to see if this approach can lead to long-term remission and potentially a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Paoli-Calmettes
RECRUITINGMarseille, Institut Paoli-calmettes, 13273, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- Could an ALS drug clear the fog of chemo brain?
- Ancient Mind-Body practice tested as fatigue fighter for men after cancer
- Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
- Drug that starves tumors shows promise against advanced kidney cancer
- Could a common bile acid pill shield kidneys during cancer surgery?